Status:

COMPLETED

Cholesterol Effects of Kori-tofu Proteins

Lead Sponsor:

Wageningen University and Research

Collaborating Sponsors:

Asahimatsu Foods

Conditions:

Lipid Metabolism Disorders

Eligibility:

All Genders

40-70 years

Phase:

NA

Brief Summary

The study is a randomized, cross-over, double-blind, controlled trial in which participants with mildly elevated levels of cholesterol will receive two 4-week interventions (e.g. kori-tofu or control)...

Detailed Description

There are several types of tofu, an example of a specific type of tofu is called Kori-tofu. Kori-tofu literally means frozen tofu. The production process of Kori-tofu leads to the formation of a highe...

Eligibility Criteria

Inclusion

  • Age between 40-70 years;
  • BMI between 18.5-35 kg/m2;
  • Total cholesterol levels \>5 mmol/L or LDL \>3 mmol/L

Exclusion

  • Use of medication/supplements/food items that may influence the study results, such as cholesterol lowering medication, Becel ProActiv (judged by our research physician);
  • Total cholesterol levels \>7 mmol/L;
  • LDL cholesterol levels \>5 mmol/L;
  • Reported slimming, medically prescribed or other extreme diets;
  • Reported weight loss or weight gain of \>5 kg in the month prior to pre-study screening;
  • Not willing to give up blood donation during the study;
  • Current smokers;
  • Alcohol intake ≥4 glasses of alcoholic beverages per day;
  • Pregnant, lactating or wishing to become pregnant in the period of the study (self-reported);
  • Abuse of soft and/or hard drugs;
  • Food allergies or intolerances for products that we use in the study;
  • Participation in another clinical trial at the same time; NL75320.081.20 CHOKO Version number: 4, April 2021 15 of 34
  • Being an employee of the Food, Health \& Consumer Research group of Wageningen Food \& Biobased Research.

Key Trial Info

Start Date :

September 7 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 7 2021

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT04896619

Start Date

September 7 2021

End Date

December 7 2021

Last Update

December 9 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wageningen University & Research

Wageningen, Gelderland, Netherlands, 6708 WG